Search Results - "Trask, C"

Phase II Study of Axitinib in Sorafenib-Refractory Metastatic Renal Cell Carcinoma by RINI, Brian I, WILDING, George, HUDES, Gary, STADLER, Walter M, KIM, Sinil, TARAZI, Jamal, ROSBROOK, Brad, TRASK, Peter C, WOOD, Laura, DUTCHER, Janice P

“…To investigate the efficacy and safety of axitinib, an oral, potent, and selective inhibitor of vascular endothelial growth factor (VEGF) receptors 1, 2, and 3…”
Get full text

Armour reduction and pelvic girdle loss in a population of threespine stickleback (Gasterosteus aculeatus) from western Newfoundland, Canada by Scott, R. J., Haines, G. E., Trask, C. A.

“…We describe the antipredator armour of a unique population of threespine stickleback ( Gasterosteus aculeatus ) from Narrows Pond in western Newfoundland and…”
Get full text

Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study by Kindler, Hedy L, Dr, Ioka, Tatsuya, MD, Richel, Dirk J, MD, Bennouna, Jaafar, MD, Létourneau, Richard, MD, Okusaka, Takuji, MD, Funakoshi, Akihiro, MD, Furuse, Junji, MD, Park, Young Suk, MD, Ohkawa, Shinichi, MD, Springett, Gregory M, MD, Wasan, Harpreet S, MB, Trask, Peter C, PhD, Bycott, Paul, PhD, Ricart, Alejandro D, MD, Kim, Sinil, MD, Van Cutsem, Eric, MD

“…Summary Background Axitinib is a potent, selective inhibitor of vascular endothelial growth factor (VEGF) receptors 1, 2, and 3. A randomised phase 2 trial of…”
Get full text

Are changes in patient-reported outcomes prognostic for diffuse large B-Cell lymphoma survival? Results from the GOYA trial by Yan, Jessie T., Bel, Célia, Trask, Peter C., Lo, Ernest

“…In this hypothesis-generating analysis, we examined whether longitudinal changes in patient-reported outcomes (PROs), such as symptoms, over time would be…”
Get full text

Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study by Rixe, Olivier, Prof, Bukowski, Ronald M, MD, Michaelson, M Dror, MD, Wilding, George, MD, Hudes, Gary R, MD, Bolte, Oliver, MD, Motzer, Robert J, MD, Bycott, Paul, DrPH, Liau, Katherine F, BS, Freddo, James, MD, Trask, Peter C, PhD, Kim, Sinil, MD, Rini, Brian I, MD

“…Summary Background Axitinib (AG-013736) is an oral, potent, and selective inhibitor of vascular endothelial growth factor receptors 1, 2, and 3. We aimed to…”
Get full text

Design and evaluation of braced touch for touchscreen input stabilisation by Cockburn, A., Masson, D., Gutwin, C., Palanque, P., Goguey, A., Yung, M., Gris, C., Trask, C.

“…•Introduces and analyses the design of Braced Touch for touch input stabilisation during vibration.•Describes an empirical validation of Braced Touch using…”
Get full text

Experience of patients and practitioners with a team and technology approach to chronic back disorder management by Lovo, Stacey, Harrison, L, O'Connell, M E, Trask, C, Bath, B

“…Although rural and remote residents face general challenges accessing health care in comparison to urban dwellers, care for musculoskeletal conditions like…”
Get full text

Microfibril-associated Glycoprotein 2 (MAGP2) Loss of Function Has Pleiotropic Effects in Vivo by Combs, Michelle D., Knutsen, Russell H., Broekelmann, Thomas J., Toennies, Holly M., Brett, Thomas J., Miller, Chantel A., Kober, Daniel L., Craft, Clarissa S., Atkinson, Jeffrey J., Shipley, J. Michael, Trask, Barbara C., Mecham, Robert P.

“…The function of MAGP2 was studied by inactivating its gene (Mfap5−/−) in mice. Results: Mfap5−/− mice have a neutrophil deficiency and other phenotypes that…”
Get full text

Assessment of Depression in Cancer Patients by Trask, Peter C.

“…It is widely known that depression exists in patients with cancer. The prevalence, however, varies widely by study and is often attributable to differences in…”
Get full text

Patient‐reported outcomes provide prognostic information for survival in patients with diffuse large B‐cell lymphoma: Analysis of 1239 patients from the GOYA study by Huang, Huang, Datye, Asim, Fan, Ming, Knapp, Andrea, Nielsen, Tina, Bottos, Alessia, Paulson, Joseph N., Trask, Peter C., Efficace, Fabio

“…Purpose We investigated the prognostic value of pretreatment patient‐reported outcomes (PROs) in patients with diffuse large B‐cell lymphoma (DLBCL) receiving…”
Get full text

Operator and Potential Exposure to Hydrogen Sulfide: A Study of the British Columbia Dairy Industry by O'Leary, T., Merkowsky, K., Trask, C., Bennett, W., Kirychuk, S.

“…Hydrogen Sulfide (H2S) is produced in manure storage facilities and released during manure agitation. Exposure to this gas presents health risks to workers at…”
Get full text

Screening for psychologic distress in ambulatory cancer patients : A multicenter evaluation of the distress thermometer by JACOBSEN, Paul B, DONOVAN, Kristine A, TRASK, Peter C, FLEISHMAN, Stewart B, ZABORA, James, BAKER, Frank, HOLLAND, Jimmie C

“…Abstract BACKGROUND Based on evidence that psychologic distress often goes unrecognized although it is common among cancer patients, clinical practice…”
Get full text

Assessing whole body vibration exposure for use in epidemiological studies of back injuries: measurements, observations and self-reports by Village, J., Trask, C., Chow, Y., Morrison, J.B., Koehoorn, M., Teschke, K.

“…Improved assessment of whole body vibration exposure is needed for epidemiological studies investigating the causes of low back disorders. Vibration was…”
Get full text

Yin-Yang1 Is Required in the Mammalian Oocyte for Follicle Expansion by GRIFFITH, Gillian J, TRASK, Mary C, HILLER, Jacob, WALENTUK, Melanie, PAWLAK, John B, TREMBLAY, Kimberly D, MAGER, Jesse

“…The multifaceted polycomb group gene Yin-Yang1 (Yy1) has been implicated in a variety of transcriptional regulatory roles both as an activator and silencer of…”
Get full text

Psychiatric Side Effects of Interferon Therapy: Prevalence, Proposed Mechanisms, and Future Directions by Trask, P C, Esper, P, Riba, M, Redman, B

“…The increasing use of interferon (IFN) in treating a variety of disorders including, malignant melanoma and hepatitis C, has resulted in the identification and…”
Get full text

Patient characteristics and treatment patterns in chronic myeloid leukemia: evidence from a multi-country retrospective medical record chart review study by Mitra, Debanjali, Trask, Peter C., Iyer, Shrividya, Candrilli, Sean D., Kaye, James A.

“…We conducted a retrospective medical record review of 1,063 patients to examine patient characteristics and treatment patterns among adults with Philadelphia…”
Get full text

Psychometrics of patient-reported bother from side effects of treatment single-items in industry-sponsored oncology trials by Trask, Peter C., Holt, Tracy, Pearman, Timothy

“…Background Improvements in cancer treatment have increased the number of cancer survivors, but also increased the long-term and late effects from cancer…”
Get full text

Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life by CULLEN, M. H, BILLINGHAM, L. J, TRASK, C, BESSELL, E, CONNOLLY, C. K, TOBIAS, J, SOUHAMI, R. L, WOODROFFE, C. M, CHETIYAWARDANA, A. D, GOWER, N. H, JOSHI, R, FERRY, D. R, RUDD, R. M, SPIRO, S. G, COOK, J. E

“…Chemotherapy for non-small-cell lung cancer (NSCLC) remains controversial. We describe the two largest reported, randomized, parallel trials designed to…”
Get full text

Patterns and prognostic indicators of response to CML treatment in a multi-country medical record review study by Trask, Peter C., Mitra, Debanjali, Iyer, Shrividya, Candrilli, Sean D., Kaye, James A.

“…We conducted a review of patient medical records to assess treatment response patterns and prognostic indicators of response among chronic myeloid leukemia…”
Get full text

Psychosocial Characteristics of Individuals With Non–Stage IV Melanoma by TRASK, Peter C, PATERSON, Amber G, HAYASAKA, Satoru, DUNN, Rodney L, RIBA, Michelle, JOHNSON, Timothy

“…Melanoma is the fastest growing solid tumor among men and women and accounts for 79% of skin cancer-related deaths. Research has identified that distress is…”
Get full text